Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA: 600867)

Tonghua Dongbao Pharmaceutical Revenue

Tonghua Dongbao Pharmaceutical had revenue of 707.73M CNY in the quarter ending September 30, 2024, a decrease of -2.41%. This brings the company's revenue in the last twelve months to 2.43B, down -12.24% year-over-year. In the year 2023, Tonghua Dongbao Pharmaceutical had annual revenue of 3.08B with 10.69% growth.

• Revenue (ttm): 2.43B
• Revenue Growth: -12.24%
• P/S Ratio: 7.85
• Revenue / Employee: 760.84K
• Employees: 3,196
• Market Cap: 17.41B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	3.08B	296.96M	10.69%
Dec 31, 2022	2.78B	-489.44M	-14.98%
Dec 31, 2021	3.27B	375.73M	12.99%
Dec 31, 2020	2.89B	115.02M	4.14%
Dec 31, 2019	2.78B	84.22M	3.13%